[
    [
        {
            "time": "",
            "original_text": "维康药业IPO：2018净利润下滑可持续盈利能力存疑 供应商屡上食药监黑榜 欺诈造假",
            "features": {
                "keywords": [
                    "维康药业",
                    "IPO",
                    "净利润下滑",
                    "盈利能力",
                    "供应商",
                    "食药监黑榜",
                    "欺诈造假"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "维康药业IPO：2018净利润下滑可持续盈利能力存疑 供应商屡上食药监黑榜 欺诈造假",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "处方药政策利好有研发能力药企 高值耗材改革有利于进口替代",
            "features": {
                "keywords": [
                    "处方药",
                    "政策利好",
                    "研发能力",
                    "药企",
                    "高值耗材",
                    "进口替代"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "处方药政策利好有研发能力药企 高值耗材改革有利于进口替代",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]